[1]
Sharma, A. et al. 2020. Bevacizumab in Retinopathy of Prematurity : Concerns and adverse effects. Nepalese Journal of Ophthalmology. 12, 2 (Oct. 2020), 298–307. DOI:https://doi.org/10.3126/nepjoph.v12i2.28993.